DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Branford S, Rudzki Z, Walsh S, Parkinson I, Grigg A, Szer J, Taylor K, Herrmann R, Seymour JF, Arthur C, Joske D, Lynch K, Hughes T.
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.
Blood 2003; 102: 276-283
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.